Dual PI3K/mTOR inhibition in combination with inhibition of autophagy to improve treatment response for BCR-ABL independent mechanisms of TKI-resistance in CML

被引：0

作者：

Mitchell, R. ^{[1
]}

Allan, E. K. ^{[2
]}

Baquero, P. ^{[1
]}

Mukhopadhyay, A. ^{[3
]}

Clark, R. ^{[4
]}

Mitra, S. ^{[5
]}

Druker, B. J. ^{[6
]}

Salomoni, P. ^{[7
]}

Calabretta, B. ^{[8
]}

Chan, E. ^{[9
]}

Nicolini, F. E. ^{[10
]}

Holyoake, T. L. ^{[3
]}

Helgason, G. V. ^{[1
]}

机构：

[1] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Wolfson Wohl Canc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland

[2] Gartnavel Royal Hosp, Scottish Natl Blood Transfus Serv, Glasgow, Lanark, Scotland

[3] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Paul OGorman Leukaemia Res Ctr, Glasgow G12 8QQ, Lanark, Scotland

[4] Univ Liverpool, Dept Mol & Clin Canc Med, Sect Haematol, Liverpool L69 3BX, Merseyside, England

[5] Milton Keynes Hosp NHS Fdn Trust, Dept Haematol, Milton Keynes, Bucks, England

[6] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA

[7] UCL Canc Inst, Samantha Dickson Brain Canc Unit, London, England

[8] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA

[9] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland

[10] Hop Edouard Herriot, Hematol Clin, Lyon, France

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

218

引用

页码：88 / 89

页数：2